7LZD image
Entry Detail
PDB ID:
7LZD
Keywords:
Title:
Crystal Structure of SETD2 bound to Compound 35
Biological Source:
PDB Version:
Deposition Date:
2021-03-09
Release Date:
2021-09-22
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.21
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Histone-lysine N-methyltransferase SETD2
Chain IDs:A
Chain Length:278
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies.
Acs Med.Chem.Lett. 12 1539 1545 (2021)
PMID: 34671445 DOI: 10.1021/acsmedchemlett.1c00272

Abstact

SET domain-containing protein 2 (SETD2), a histone methyltransferase, has been identified as a target of interest in certain hematological malignancies, including multiple myeloma. This account details the discovery of EPZ-719, a novel and potent SETD2 inhibitor with a high selectivity over other histone methyltransferases. A screening campaign of the Epizyme proprietary histone methyltransferase-biased library identified potential leads based on a 2-amidoindole core. Structure-based drug design (SBDD) and drug metabolism/pharmacokinetics (DMPK) optimization resulted in EPZ-719, an attractive tool compound for the interrogation of SETD2 biology that enables in vivo target validation studies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures